|
schizophrenia |
24 |
|
covid-19 |
19 |
|
child psychosocial problems |
16 |
|
coronavirus |
16 |
|
healthcare workers |
16 |
|
home confinement |
16 |
|
hospital policies |
16 |
|
perceived stress |
16 |
|
psychological wellbeing |
16 |
|
school closure |
16 |
|
cost-effectiveness |
15 |
|
first episode |
15 |
|
psychotic disorders |
15 |
|
first-episode schizophrenia |
14 |
|
early intervention |
13 |
|
insight |
13 |
|
symptomatology |
13 |
|
evaluation |
12 |
|
outcome |
12 |
|
recurrence |
12 |
|
remission |
12 |
|
risk factors |
12 |
|
community-based intervention |
10 |
|
first-episode psychosis |
10 |
|
stigma |
10 |
|
youth mental health |
10 |
|
youth-friendly |
10 |
|
assessment |
9 |
|
executive function |
9 |
|
delusions |
8 |
|
delusions - diagnosis |
8 |
|
delusions - etiology |
8 |
|
duration of untreated psychosis |
8 |
|
hong kong |
8 |
|
interview, psychological - methods |
8 |
|
long-term outcome |
8 |
|
mass screening - methods |
8 |
|
predictors |
8 |
|
prospective study |
8 |
|
psychiatric status rating scales |
8 |
|
psychotic disorders - complications |
8 |
|
schizophrenic psychology |
8 |
|
self-reference |
8 |
|
adolescent |
7 |
|
adult |
7 |
|
age factors |
7 |
|
behavioral symptoms - etiology - psychology - therapy |
7 |
|
cognition disorders - etiology |
7 |
|
cognitive function |
7 |
|
course |
7 |
|
female |
7 |
|
first-episode schizophrenia spectrum disorder |
7 |
|
follow-up studies |
7 |
|
humans |
7 |
|
male |
7 |
|
neuropsychological tests |
7 |
|
persistent primary negative symptoms |
7 |
|
predictive value of tests |
7 |
|
prognosis |
7 |
|
psychotic disorders - diagnosis |
7 |
|
recovery |
7 |
|
remission induction |
7 |
|
schizophrenia - complications |
7 |
|
schizophrenia - complications - diagnosis - epidemiology - therapy |
7 |
|
sex factors |
7 |
|
stability |
7 |
|
time factors |
7 |
|
adults |
6 |
|
affective psychoses |
6 |
|
anxiety |
6 |
|
anxiety disorders |
6 |
|
asia |
6 |
|
blinking |
6 |
|
clinical predictors |
6 |
|
clozapine-resistant schizophrenia |
6 |
|
cognition |
6 |
|
cognitive impairment |
6 |
|
communityolder |
6 |
|
culture |
6 |
|
delivery of health care - standards |
6 |
|
depression |
6 |
|
diminished expression |
6 |
|
dopamine |
6 |
|
early intervention service |
6 |
|
early medical intervention - standards |
6 |
|
epidemiology |
6 |
|
interview, psychological |
6 |
|
lifetime prevalence |
6 |
|
long-term outcomes |
6 |
|
longitudinal follow-up |
6 |
|
memory |
6 |
|
mental health services - standards |
6 |
|
negative symptoms |
6 |
|
population surveys |
6 |
|
prevalence |
6 |
|
treatment resistant schizophrenia |
6 |
|
diagnostic specificity |
5 |
|
functioning |
5 |
|
neurological examination abnormalities |
5 |
|
psychotic symptoms |
5 |
|
review |
5 |
|
trait |
5 |
|
mental health |
4 |
|
psychosis |
4 |
|
affective disorders |
3 |
|
brain |
3 |
|
china |
3 |
|
communication |
3 |
|
community |
3 |
|
housing |
3 |
|
lateral ventricles |
3 |
|
living environment |
3 |
|
magnetic resonance imaging |
3 |
|
needs assessment |
3 |
|
neighbourhood |
3 |
|
physician-patient relations |
3 |
|
psychological distress |
3 |
|
questionnaires |
3 |
|
suicide attempt |
3 |
|
adherence |
2 |
|
antipsychotics |
2 |
|
chinese caregivers |
2 |
|
chinese health beliefs |
2 |
|
curriculum development |
2 |
|
family burdens |
2 |
|
first-episode psychotic disorder |
2 |
|
international |
2 |
|
longitudinal |
2 |
|
mental illness |
2 |
|
rehabilitation |
2 |
|
relapse |
2 |
|
teaching methods |
2 |
|
weight dissatisfaction |
2 |
|
weight perception |
2 |
|
acute mania |
1 |
|
artificial neural network |
1 |
|
at-risk mental state |
1 |
|
backpropagation rule |
1 |
|
bipolar disorder |
1 |
|
case management |
1 |
|
cognitive-behavioural therapy |
1 |
|
eastern europe |
1 |
|
lithium |
1 |
|
motor program |
1 |
|
multilayer perceptron |
1 |
|
patient admission |
1 |
|
schizophrenia/drug therapy |
1 |
|
social behaviour |
1 |
|
south east asia |
1 |
|
treatment outcome |
1 |
|
ultra-high risk for psychosis |
1 |
|
valproate |
1 |
